OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients
Jiayu Liang, Zhida Sun
Journal of Oral Pathology and Medicine (2020) Vol. 50, Iss. 4, pp. 371-377
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
Haotian Qin, Juan Xu, Yaohang Yue, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3

IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
Xin Xu, Jiangtao Cui, Hong Wang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100503-100503
Open Access | Times Cited: 61

Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101952-101952
Open Access | Times Cited: 13

Genetic and phenotypic profiling of single living circulating tumor cells from patients with microfluidics
Zaizai Dong, Yusen Wang, Gaolian Xu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Open Access | Times Cited: 11

CD98 heavy chain as a prognostic biomarker and target for cancer treatment
Xia Pu, Anna Dubrovska
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
Yang Wang, Tianfu Liu, Xiang Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33

SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway
Fangxing Wu, Gaoyun Xiong, Zejun Chen, et al.
Hereditas (2022) Vol. 159, Iss. 1
Open Access | Times Cited: 26

Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma
Changjiang Liu, Liu Y, Yifeng Yu, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 20

Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors
Jiajun He, Dong Liu, Mei Liu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 20

Prognosis Prediction of Disulfidptosis-Related Genes in Bladder Cancer and a Comprehensive Analysis of Immunotherapy
Chonghao Jiang, Yonggui Xiao, Danping Xu, et al.
Critical Reviews in Eukaryotic Gene Expression (2023) Vol. 33, Iss. 6, pp. 73-86
Closed Access | Times Cited: 9

Fresh Medium or L-Cystine as an Effective Nrf2 Inducer for Cytoprotection in Cell Culture
Wujing Dai, Qin M. Chen
Cells (2023) Vol. 12, Iss. 2, pp. 291-291
Open Access | Times Cited: 8

Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers
Pei‐Ling Hsieh, Shih‐Chi Chao, Pei‐Ming Chu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3142-3142
Open Access | Times Cited: 10

Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte
Zihan Chen, Rongxue Li, Min Fang, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 8, pp. 1060-1078
Open Access | Times Cited: 6

The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2
Maihulan Maimaiti, Shinichi Sakamoto, Masahiro Sugiura, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12

Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance
Cameron Geller, Joanna Joyce Maddela, Ranel Tuplano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer
Meijun Zheng, Zeng Wang, M. Li, et al.
Translational Oncology (2024) Vol. 45, pp. 101981-101981
Open Access | Times Cited: 1

Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer
Tongtong Zhang, Suyang Yu, Shipeng Zhao
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 1, pp. 84-101
Open Access | Times Cited: 4

Downregulation of SLC3A2 mediates immune evasion and accelerates metastasis in oral squamous cell carcinoma
Jiang En Wu, You Li, Jun Hou
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 2

Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles
Inga Solgård Juvkam, Olga Zlygosteva, Mateusz Sitarz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16983-16983
Open Access | Times Cited: 2

SLC7A5 expression is up-regulated in peripheral blood T and B lymphocytes of systemic lupus erythematosus patients, associating with renal damage
Juan Tian, Xiaowei Li, Yiru Jiang, et al.
Clinical Immunology (2022) Vol. 237, pp. 108987-108987
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top